NIKKEI 225
40,780.70 -131.67 (-0.32%) HANG SENG
17,524.06 -275.55 (-1.55%) CRUDE OIL
82.22 -0.94 (-1.13%) GOLD FUTURES
2,366.40 -31.30 (-1.31%) DOW
39,344.79 -31.08 (-0.08%) Bitcoin GBP
44,214.56 +80.29 (+0.18%)
Baxter International Inc. (BAX.MX)
| Previous close | 613.81 |
| Open | 608.88 |
| Bid | 608.88 x 1100 |
| Ask | 0.00 x 1300 |
| Day's range | 608.88 - 608.88 |
| 52-week range | 569.11 - 820.00 |
| Volume | |
| Avg. volume | 266 |
| Market cap | 319.587B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 21.22 (3.46%) |
| Ex-dividend date | 31 May 2024 |
| 1y target est | N/A |
- Business Wire
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
DEERFIELD, Ill., June 06, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time.
- Business Wire
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
DEERFIELD, Ill., May 29, 2024--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis (HF HD). The study, "Survival of expanded hemodialysis and high-flux hemodialysis patients in Colombia: a cohort study," was prese
- Business Wire
Baxter to Present at Jefferies 2024 Global Healthcare Conference
DEERFIELD, Ill., May 23, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, December 2, 2024.
